Speed and oversight: FDA Commissioner Gottlieb acts on pledges

In late August, in a rare tide of bipartisan support, the US Congress passed legislation to reauthorize user fee programs for the next five years…

Para acessar a publicação na íntegra clique  aqui

 

Fonte: NATURE BIOTECHNOLOGY VOLUME 35 NUMBER 10 OCTOBER 2017